Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Canada)

Index « Auteurs » - entrée « Melanie E. Powell »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Melanie Dunstan < Melanie E. Powell < Melanie F. Heath  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000464 (2016) Stephanie M. De Boer [Pays-Bas] ; Melanie E. Powell [Royaume-Uni] ; Linda Mileshkin [Australie] ; Dionyssios Katsaros [Italie] ; Paul Bessette [Canada] ; Christine Haie-Meder [France] ; Petronella B. Ottevanger [Pays-Bas] ; Jonathan A. Ledermann [Royaume-Uni] ; Pearly Khaw [Australie] ; Alessandro Colombo [Italie] ; Anthony Fyles [Canada] ; Marie-Helene Baron [France] ; Henry C. Kitchener [Royaume-Uni] ; Hans W. Nijman [Pays-Bas] ; Roy F. Kruitwagen [Pays-Bas] ; Remi A. Nout [Pays-Bas] ; Karen W. Verhoeven-Adema [Pays-Bas] ; Vincent T. Smit [Pays-Bas] ; Hein Putter [Pays-Bas] ; Carien L. Creutzberg [Pays-Bas]Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.
000534 (2016) Inge C. Van Gool [Pays-Bas] ; Ellen Stelloo [Pays-Bas] ; Remi A. Nout [Pays-Bas] ; Hans W. Nijman [Pays-Bas] ; Richard J. Edmondson [Royaume-Uni] ; David N. Church [Royaume-Uni] ; Helen J. Mackay [Canada] ; Alexandra Leary [France] ; Melanie E. Powell [Royaume-Uni] ; Linda Mileshkin [Australie] ; Carien L. Creutzberg [Pays-Bas] ; Vincent T H B M. Smit [Pays-Bas] ; Tjalling Bosse [Pays-Bas]Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
000846 (2015) Ellen Stelloo [Pays-Bas] ; Tjalling Bosse [Pays-Bas] ; Remi A. Nout [Pays-Bas] ; Helen J. Mackay [Canada] ; David N. Church [Royaume-Uni] ; Hans W. Nijman [Pays-Bas] ; Alexandra Leary [France] ; Richard J. Edmondson [Royaume-Uni] ; Melanie E. Powell [Royaume-Uni] ; Emma J. Crosbie [Royaume-Uni] ; Henry C. Kitchener [Royaume-Uni] ; Linda Mileshkin [Australie] ; Pamela M. Pollock [Australie] ; Vincent T. Smit [Pays-Bas] ; Carien L. Creutzberg [Pays-Bas]Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Aged
3Endometrial Neoplasms (pathology)
3Female
3Humans
3Middle Aged
2Adult
2Biomarkers, Tumor (analysis)
2DNA Mutational Analysis
2Endometrial Neoplasms (genetics)
2Endometrial Neoplasms (therapy)
2Immunohistochemistry
2Kaplan-Meier Estimate
2Neoplasm Grading
2Neoplasm Invasiveness
2Neoplasm Staging
2Prognosis
2Risk Factors
1Adenocarcinoma, Clear Cell (radiotherapy)
1Adenocarcinoma, Clear Cell (secondary)
1Adenocarcinoma, Clear Cell (therapy)
1Aged, 80 and over
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Biomarkers, Tumor (genetics)
1Carboplatin (administration & dosage)
1Carcinoma, Endometrioid (chemistry)
1Carcinoma, Endometrioid (genetics)
1Carcinoma, Endometrioid (mortality)
1Carcinoma, Endometrioid (secondary)
1Carcinoma, Endometrioid (therapy)
1Case-Control Studies
1Chemoradiotherapy, Adjuvant (adverse effects)
1Cisplatin (administration & dosage)
1Cystadenocarcinoma, Serous (radiotherapy)
1Cystadenocarcinoma, Serous (secondary)
1Cystadenocarcinoma, Serous (therapy)
1Disease Progression
1Disease-Free Survival
1Endometrial Neoplasms (chemistry)
1Endometrial Neoplasms (classification)
1Endometrial Neoplasms (mortality)
1Endometrial Neoplasms (radiotherapy)
1Follow-Up Studies
1Gastrointestinal Diseases (diagnosis)
1Gastrointestinal Diseases (etiology)
1Genetic Predisposition to Disease
1Hematologic Diseases (diagnosis)
1Hematologic Diseases (etiology)
1Lymphatic Metastasis
1Mutation
1Neoplasm Recurrence, Local
1Nervous System Diseases (diagnosis)
1Nervous System Diseases (etiology)
1Neural Cell Adhesion Molecule L1 (analysis)
1Paclitaxel (administration & dosage)
1Phenotype
1Pilot Projects
1Polymerase Chain Reaction
1Quality of Life
1Radiotherapy, Adjuvant (adverse effects)
1Retrospective Studies
1Risk Assessment
1Survival Rate
1Tissue Array Analysis
1Treatment Outcome
1Tumor Suppressor Protein p53 (genetics)
1Young Adult

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Melanie E. Powell" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "Melanie E. Powell" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Melanie E. Powell
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024